BENGALURU: Johnson & Johnson (J&J) said on Tuesday that it was in talks with the Indian government to explore ways to speed up delivery of its singleshot Covid-19 vaccine in the country. The company also said as per a recent announcement by the Indian drug regulator, there is no longer a need to conduct bridging clinical trials of the vaccines in India.
The US-based company said in April it was seeking an approval to conduct a bridging clinical study of its Janssen Covid-19 vaccine candidate in India. In May, however, the country scrapped local trials for “well-established” vaccines manufactured in other countries.
1OO million J&J COVID vaccines likely to be procured from EU for India by NGO
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.
1OO million J & J COVID vaccines likely to be procured from EU for India by NGO
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.